Partner, Managing Director Benelux, Head of Consumer
14.50-
Healthcare sector update
Richard Relyea
15.30
and Cirtec Medical
Partner, Managing Director North America, Head of Healthcare
Q&A
15.30-
WilsonHCG
Rahul Lulla
16.10
Q&A
Partner, North America
16.10-
Closing remarks and
Simon Borrows
16.30
final questions
Chief Executive
3
Portfolio update
Investment portfolios continue to make good progress in challenging markets
Private Equity portfolio:
Assets in value for money consumer, healthcare, specialty industrial and business and technology services have generated strong earnings growth and have good momentum as we head into H2 FY23. We also see sustained increase in demand across travel related assets in the portfolio
Assets exposed to discretionary spending continue to see headwinds, but encouraged by pricing power shown by a number of the more challenged companies, as well as ability to use other levers to partially mitigate inflation impacts
Action's impressive performance continues with very strong sales and EBITDA growth; significant new customer flow driven by very low prices and good product availability
YTD sales at over €5.8bn are over 26% ahead of the same period last year
Expect LTM EBITDA to the end of P9 to be c.€1,035m compared to €765m at September last year and €506 million at September 2019
Continued strong cash generation with net debt now standing at less than 2.1x run-rate EBITDA
142 new stores opened to date in 2022; on track to open more new stores in 2022 than in 2021
Energy costs for 2022 estimated to total less than 0.4% of sales
International investments (non-sterling) account for 87% of 3i's investment portfolio
4
Today's seminar
2016
Urban living designer
2021
Global winner in talent solutions
2017
Outsourced medical device manufacturing
5
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
3i Group plc published this content on 26 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 September 2022 12:34:04 UTC.
3i Group plc is one of Europe's largest capital investment companies. At the end of March 2023, the group's portfolio had a market value of GBP 18.4 billion, broken down by type of operation as follows:
- private equity (89.1%): investments in medium-sized enterprises, operating in the business and technology services, industry, health and consumer goods sectors, located primarily in Europe and North America. The group also manages funds on behalf of third parties;
- investment in infrastructure assets (7.6%): activity insured primarily in Europe;
- other (3.3%).
The portfolio in value breaks down by type of participation between unlisted companies (94.8%) and listed companies (5.2%).